Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Adenocarcinoma
8%
Adjuvant Chemoradiotherapy
41%
Adjuvant Chemotherapy
9%
Adjuvant Radiotherapy
28%
Arm
5%
Axillary Lymph Node
6%
Bile Duct Cancer
40%
Biological Marker
5%
Brain Metastasis
16%
Breast Cancer
100%
Breast Radiotherapy
17%
Breast Tumor
6%
Cancer Specific Survival
5%
Carcinoembryonic Antigen
7%
Cervical Cancer
6%
Cholangiocarcinoma
10%
Conservative Treatment
6%
Disease Free Survival
36%
Distant Metastasis
17%
Distant Metastasis Free Survival
20%
Epidermal Growth Factor Receptor 2
6%
Extrahepatic Bile Duct
37%
Fluorouracil
10%
Gamma Urogastrone
6%
Hazard Ratio
17%
Hepatocellular Carcinoma
14%
Intensity Modulated Radiation Therapy
13%
Internal Mammary Lymph Node
6%
Internal Mammary Node
5%
Intraductal Carcinoma
8%
Local Recurrence Free Survival
14%
Lymph Node
29%
Lymph Node Irradiation
7%
Lymph Node Metastasis
12%
Magnetic Resonance Imaging
5%
Mastectomy
26%
Meta-Analysis
8%
Metastatic Carcinoma
7%
Minimal Residual Disease
6%
Neoadjuvant Chemotherapy
20%
Neoplasm
60%
Overall Survival
73%
Pancreaticoduodenectomy
7%
Pelvis
9%
Phyllodes Tumor
7%
Prognostic Factor
39%
Progression Free Survival
7%
Propensity Score Matching
8%
Quadrantectomy
36%
Recurrence Free Survival
11%
Recurrence Risk
6%
Recurrent Disease
51%
Retroperitoneal Lymph Node Dissection
5%
Retrospective Study
29%
Risk Stratification
5%
Squamous Cell Carcinoma
7%
Supraclavicular Lymph Node
8%
Surgical Margin
16%
Surveillance, Epidemiology, and End Results
7%
Survival Rate
35%
Survivin
5%
Systemic Therapy
9%
Thoracic Wall
5%
Tumor Infiltrating Lymphocyte
5%
Tumor Recurrence
5%
Volumetric Modulated Arc Therapy
8%
Whole Brain Radiotherapy
11%
Pharmacology, Toxicology and Pharmaceutical Science
Adenocarcinoma
6%
Bile Duct Cancer
22%
Bile Duct Carcinoma
5%
Brain Metastasis
7%
Breast Cancer
35%
Disease Free Survival
20%
Distant Metastasis
10%
Distant Metastasis Free Survival
15%
Fluorouracil
16%
Liver Cell Carcinoma
9%
Local Recurrence Free Survival
12%
Lymph Node Metastasis
8%
Neoplasm
47%
Overall Survival
52%
Phyllodes Tumor
7%
Progression Free Survival
7%
Recurrence Free Survival
10%
Recurrent Disease
35%
Retrospective Study
14%
Squamous Cell Carcinoma
5%
Survival Rate
29%